
14 February 2022
01 42 54 60 64 | contact@welcomeurope.com
To view this information , thank you for logging in.
To view this information , thank you for logging in.
To view this information , thank you for logging in.
Objective
To develop early warning mechanisms and guidance in the area of pricing through the EURIPID database, based on lessons from competition cases, in particular on excessive pricing.
Priorities
Among financed actions
Monitoring of strategic sequencing of price increases of threats to de-list reimbursable medicines or withdraw of medicines.
Additional information
Eligibility
14 February 2022